Articoli

Una sola analisi, una sola colonna, meno di 9 minuti per oltre 60 antibiotici multiclasse

Applicazione descritta: Antibiotici veterinari multiclasse in LC-MS/MS sulla Raptor C18

29 Oct 2020

feature FSSS2276
  • Separazione dei picchi altamente efficiente e tempi di analisi rapidi.
  • Applicabilità universale per l’analisi residuale degli antibiotici, con possibilità di ottimizzare l’analisi di singole classi di composti ai fini della quantificazione:
    • Macrolidi, lincosamidi, e streptogramine (Figura 1)
    • Amfenicoli e tetracicline (Figura 2)
    • Chinoloni (Figura 3)
    • Penicilline, cefalosporine e tetracicline (Figura 4)
    • Sulfamidici (Figura 5) (Per gli ionofori è stata utilizzata la Raptor bifenilica. Figura 6)

L’uso di antibiotici sugli animali destinati alla produzione alimentare è un problema di salute e sicurezza pubblica in quanto potrebbero svilupparsi batteri farmacoresistenti. Molti paesi dell’Unione europea e il Canada hanno vietato l’uso di questi farmaci per scopi non terapeutici, e gli Stati Uniti stanno implementando una politica volta a ridurre l’uso di antibiotici di rilievo clinico come promotori della crescita. Per regolamentare l’uso corretto degli antibiotici veterinari, la statunitense FDA ha fissato i limiti massimi dei residui (LMR) per diversi tessuti animali e prodotti alimentari (21 CFR Part 556). Per operare in conformità a queste disposizioni è necessario impiegare un metodo analitico sensibile, efficiente e affidabile per diverse classi di antibiotici, e la colonna LC Raptor C18 è la scelta ideale.

Multiclass Veterinary Antibiotics on Raptor C18 by LC-MS/MS

LC_FS0506

Peaks

PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
1.Desacetyl cephapirin0.70150382.03111.92124.21
2.Sulfanilamide0.85200172.9893.0775.23
3.Amoxicillin0.92100366.24349.10208.07
4.Cephapirin1.3650424.17292.08124.14
5.Tildipirosin1.38200734.59561.45204.15
6.Desfuroyl ceftiofur cysteine disulfide1.40300549.16183.02126.00
7.Lincomycin1.5050407.32359.23389.28
8.Sulfadiazine1.5720251.18156.0492.08
9.Cefquinome1.73200529.19134.10125.12
10.Ampicillin1.7850350.19106.07160.06
11.Sulfathiazole1.7910256.16156.0392.08
12.Marbofloxacin1.8110363.2072.11320.10
13.Cefalexin1.82100348.10158.05174.05
14.Sulfapyridine1.8610250.13156.1092.08
15.Norfloxacin1.9620320.23276.20233.13
16.Ofloxacin1.9810362.21318.20261.15
17.Sulfamerazine2.0020265.08156.0392.08
18.Cefalonium2.01100459.16337.03123.10
19.Oxytetracycline2.0225461.27426.15443.32
20.Ciprofloxacin2.0420332.18288.22245.15
21.Cefacetrile2.09300362.07258.08178.01
22.Tulathromycin A2.11100806.65577.42420.31
23.Tetracycline2.2125445.28154.07427.32
24.Danofloxacin2.2320358.22340.16314.21
25.Enrofloxacin2.3210360.29316.22245.13
26.Orbifloxacin2.3510396.22352.17226.12
27.Thiamphenicol*2.38200354.16290.04184.98
28.Sulfamethazine2.3910279.23186.08124.08
29.Sulfamethizole2.5210271.17156.02108.02
30.Sulfamethoxypyridazine2.5610281.14156.03126.07
31.Sarafloxacin2.5910386.20342.20368.15
32.Difloxacin2.6510400.23356.17299.13
33.Cefazolin2.75100455.10323.06295.09
34.Spiramycin2.96200843.64540.36699.48
35.Pirlimycin3.0520411.32363.18327.21
36.Chlortetracycline3.0825479.27154.07371.06
37.Sulfachlorpyridazine3.1220285.05156.03108.09
38.Gamithromycin3.28100777.63619.52601.45
39.Sulfadoxine3.3910311.17156.03108.09
40.Sulfamethoxazole3.4620254.18155.98147.06
41.Cefoperazone3.52100646.26143.07148.02
42.Florfenicol*3.55200356.10336.02184.98
43.Sulfaethoxypyridazine3.5620295.17267.07156.03
44.Tilmicosin3.64100869.72696.50522.42
45.Sulfisoxazole3.7620268.14156.03113.10
46.Oxolinic acid3.945262.10244.06215.96
47.Chloramphenicol*4.00200321.16151.99257.04
48.Ceftiofur4.1150524.14241.08125.24
49.Erythromycin4.3125734.64576.40558.38
50.Sulfadimethoxine4.3610311.17156.09108.09
51.Sulfaquinoxaline4.4220301.18156.04108.02
52.Tylosin**4.67100916.62772.49598.36
53.Penicillin G5.07100335.18176.07160.07
54.Flumequine5.345262.15244.11202.03
55.Penicillin V5.56100351.10160.06114.07
56.Oxacillin5.99100402.15160.05114.06
57.Virginiamycin M16.1350526.43508.31355.10
58.Tylvalosin6.19501042.71814.46640.39
59.Cloxacillin6.39100436.15277.06160.05
60.Nafcillin6.6025415.19199.09171.06
61.Dicloxacillin6.96100470.11160.05311.02
*Acquired in negative ion mode

Conditions

ColumnRaptor C18 (cat.# 9304A12)
Dimensions:100 mm x 2.1 mm ID
Particle Size:2.7 µm
Pore Size:90 Å
Guard Column:Raptor C18 EXP guard column cartridge 5 mm, 2.1 mm ID, 2.7 µm (cat.# 9304A0252)
Temp.:35 °C
Standard/Sample
Diluent:Water
Conc.:5–300 ng/mL
Inj. Vol.:2 µL
Mobile Phase
A:0.1% Formic acid in water
B:0.1% Formic acid in acetonitrile
Time (min)Flow (mL/min)%A%B
0.000.49010
4.500.46535
7.000.44555
7.010.49010
9.000.49010
DetectorMS/MS
Ion Mode:ESI+/ESI-
Mode:Scheduled MRM
InstrumentUHPLC
Notes1. Positive and negative polarity data were collected simultaneously from a single injection.
2. Amphenicol compounds (chloramphenicol, thiamphenicol, and florfenicol) were detected with negative polarity.
3. The MRM was scheduled at +/- 20 to 30 seconds for each analyte.
4. Multiclass antibiotics include penicillin, cephalosporin, tetracycline, sulfonamide, macrolide, lincosamide, streptogramin, amphenicol, and quinolone.
**The retention time for Tylosin is noted in the peak list; however, it was not included in the chromatogram.

Want even better performance when analyzing metal-sensitive compounds? Check out Inert LC columns at www.restek.com/inert.
Figura 1: Macrolidi, lincosamidi e streptogramine in LC-MS/MS sulla Raptor C18
Macrolide, Lincosamide, and Streptogramin Antibiotics on Raptor C18 by LC-MS/MS

LC_FS0502

Peaks

PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
1.Tildipirosin1.01200734.59561.45204.15
2.Lincomycin1.1150407.32359.23389.28
3.Tulathromycin A1.19100806.65577.42420.31
4.Spiramycin1.41200843.64540.36699.48
5.Pirlymycin1.4920411.32363.18327.21
PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
6.Gamithromycin1.50100777.63619.52601.45
7.Tilmicosin1.58100869.72696.50522.42
8.Erythromycin1.8025734.64576.40558.38
9.Tylosin1.87100916.62772.49598.36
10.Tylvalosin2.30501042.71814.46640.39
11.Virginiamycin M12.4550526.43508.31355.10

Conditions

ColumnRaptor C18 (cat.# 9304A12)
Dimensions:100 mm x 2.1 mm ID
Particle Size:2.7 µm
Pore Size:90 Å
Guard Column:Raptor C18 EXP guard column cartridge 5 mm, 2.1 mm ID, 2.7 µm (cat.# 9304A0252)
Temp.:40 °C
Standard/Sample
Diluent:Water
Conc.:20–200 ng/mL
Inj. Vol.:2 µL
Mobile Phase
A:0.1% Formic acid in water
B:0.1% Formic acid in acetonitrile
Time (min)Flow (mL/min)%A%B
0.000.49010
3.000.42080
3.010.49010
5.000.49010
DetectorMS/MS
Ion Mode:ESI+
Mode:MRM
InstrumentUHPLC
NotesWant even better performance when analyzing metal-sensitive compounds? Check out Inert LC columns at www.restek.com/inert.
Figura 2: Amfenicoli e tetracicline in LC-MS/MS sulla Raptor C18
Amphenicol and Tetracycline Antibiotics on Raptor C18 by LC-MS/MS

LC_FS0504

Peaks

PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
1.Oxytetracycline1.2825461.27426.15443.32
2.Tetracycline1.3425445.28154.07427.32
3.Thiamphenicol*1.48200354.16290.04184.98
4.Chlortetracycline1.5625479.27154.07371.06
5.Florfenicol*1.86200356.10336.02184.98
6.Chloramphenicol*1.95200321.16151.99257.04
*Acquired in negative ion mode.

Conditions

ColumnRaptor C18 (cat.# 9304A12)
Dimensions:100 mm x 2.1 mm ID
Particle Size:2.7 µm
Pore Size:90 Å
Guard Column:Raptor C18 EXP guard column cartridge 5 mm, 2.1 mm ID, 2.7 µm (cat.# 9304A0252)
Temp.:40 °C
Standard/Sample
Diluent:Water
Conc.:25–200 ng/mL
Inj. Vol.:2 µL
Mobile Phase
A:0.1% Formic acid in water
B:0.1% Formic acid in acetonitrile
Time (min)Flow (mL/min)%A%B
0.000.49010
3.000.42080
3.010.49010
5.000.49010
DetectorMS/MS
Ion Mode:ESI+/ESI-
Mode:MRM
InstrumentUHPLC
NotesTetracyclines and amphenicols were analyzed with ESI+ and ESI- mode, respectively.

Want even better performance when analyzing metal-sensitive compounds? Check out Inert LC columns at www.restek.com/inert.
Figura 3: Chinoloni in LC-MS/MS sulla Raptor C18
Quinolone Antibiotics on Raptor C18 by LC-MS/MS

LC_FS0505

Peaks

PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
1.Marbofloxacin1.2810363.2072.11320.10
2.Norfloxacin1.3220320.23276.20233.13
3.Ofloxacin1.3210362.21318.20261.15
4.Ciprofloxacin1.3520332.18288.22245.15
5.Danofloxacin1.4020358.22340.16314.21
PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
6.Enrofloxacin1.4410360.29316.22245.13
7.Orbifloxacin1.4710396.22352.17226.12
8.Sarafloxacin1.5510386.20342.20368.15
9.Difloxacin1.5710400.23356.17299.13
10.Oxolinic acid2.235262.10244.06215.96
11.Flumequine2.785262.15244.11202.03

Conditions

ColumnRaptor C18 (cat.# 9304A12)
Dimensions:100 mm x 2.1 mm ID
Particle Size:2.7 µm
Pore Size:90 Å
Guard Column:Raptor C18 EXP guard column cartridge 5 mm, 2.1 mm ID, 2.7 µm (cat.# 9304A0252)
Temp.:40 °C
Standard/Sample
Diluent:Water
Conc.:5–20 ng/mL
Inj. Vol.:2 µL
Mobile Phase
A:0.1% Formic acid in water
B:0.1% Formic acid in acetonitrile
Time (min)Flow (mL/min)%A%B
0.000.49010
3.000.44060
3.010.49010
5.000.49010
DetectorMS/MS
Ion Mode:ESI+
Mode:MRM
InstrumentUHPLC
NotesWant even better performance when analyzing metal-sensitive compounds? Check out Inert LC columns at www.restek.com/inert.
Figura 4: Penicilline, cefalosporine, e tetracicline in LC-MS/MS sulla Raptor C18
Penicillin, Cephalosporin, and Tetracycline Antibiotics on Raptor C18 by LC-MS/MS

LC_FS0500

Peaks

PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
1.Desacetyl cephapirin0.68150382.03111.92124.21
2.Amoxicillin0.89100366.24349.10208.07
3.Cephapirin1.0550424.17292.08124.14
4.Desfuroyl ceftiofur cysteine disulfide1.06300549.16183.02126.00
5.Cefquinome1.16200529.19134.10125.12
6.Ampicillin1.1850350.19106.07160.06
7.Cefalexin1.19100348.10158.05174.05
8.Oxytetracycline1.2650461.27426.15443.32
9.Cefalonium1.29100459.16337.03123.10
10.Tetracycline1.3250445.28154.07427.32
PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
11.Cefacetrile1.37300362.07258.08178.01
12.Cefazolin1.50100455.10323.06295.09
13.Chlortetracycline1.5450479.27154.07371.06
14.Cefoperazone1.69100646.26143.07148.02
15.Ceftiofur1.8550524.14241.08125.24
16.Penicillin G2.18100335.18176.07160.07
17.Penicillin V2.33100351.10160.06114.07
18.Oxacillin2.44100402.15160.05114.06
19.Cloxacillin2.56100436.15277.06160.05
20.Nafcillin2.6325415.19199.09171.06
21.Dicloxacillin2.76100470.11160.05311.02

Conditions

ColumnRaptor C18 (cat.# 9304A12)
Dimensions:100 mm x 2.1 mm ID
Particle Size:2.7 µm
Pore Size:90 Å
Guard Column:Raptor C18 EXP guard column cartridge 5 mm, 2.1 mm ID, 2.7 µm (cat.# 9304A0252)
Temp.:40 °C
Standard/Sample
Diluent:Water
Conc.:25–300 ng/mL
Inj. Vol.:2 µL
Mobile Phase
A:0.1% Formic acid in water
B:0.1% Formic acid in acetonitrile
Time (min)Flow (mL/min)%A%B
0.000.49010
3.000.42080
3.010.49010
5.000.49010
DetectorMS/MS
Ion Mode:ESI+
Mode:MRM
InstrumentUHPLC
NotesWant even better performance when analyzing metal-sensitive compounds? Check out Inert LC columns at www.restek.com/inert.
Figura 5: Sulfamidici in LC-MS/MS sulla Raptor C18
Sulfonamide Antibiotics on Raptor C18 by LC-MS/MS

LC_FS0501

Peaks

PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
1.Sulfanilamide0.83200172.9893.0775.23
2.Sulfadiazine1.4520251.18156.0492.08
3.Sulfathiazole1.6010256.16156.0392.08
4.Sulfapyridine1.6710250.13156.1092.08
5.Sulfamerazine1.7920265.08156.0392.08
6.Sulfamethazine2.0710279.23186.08124.08
7.Sulfamethizole2.1110271.17156.02108.02
PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
8.Sulfamethoxypyridazine2.1610281.14156.03126.07
9.Sulfachlorpyridazine2.5520285.05156.03108.09
10.Sulfadoxine2.7510311.17156.03108.09
11.Sulfamethoxazole2.7820254.18155.98147.06
12.Sulfaethoxypyridazine2.8420295.17267.07156.03
13.Sulfisoxazole2.9820268.14156.03113.10
14.Sulfadimethoxine3.3710311.17156.09108.09
15.Sulfaquinoxaline3.4020301.18156.04108.02

Conditions

ColumnRaptor C18 (cat.# 9304A12)
Dimensions:100 mm x 2.1 mm ID
Particle Size:2.7 µm
Pore Size:90 Å
Guard Column:Raptor C18 EXP guard column cartridge 5 mm, 2.1 mm ID, 2.7 µm (cat.# 9304A0252)
Temp.:40 °C
Standard/Sample
Diluent:Water
Conc.:10–200 ng/mL
Inj. Vol.:2 µL
Mobile Phase
A:0.1% Formic acid in water
B:0.1% Formic acid in acetonitrile
Time (min)Flow (mL/min)%A%B
0.000.49010
3.500.46040
3.510.49010
5.000.49010
DetectorMS/MS
Ion Mode:ESI+
Mode:MRM
InstrumentUHPLC
Figura 6: Ionofori in LC-MS/MS sulla Raptor C18
Ionophore Antibiotics on Raptor Biphenyl by LC-MS/MS

LC_FS0503

Peaks

PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
1.Lasalocid A1.92100613.42377.28595.40
2.Monensin2.12100693.50675.44461.30
3.Salinomycin2.19100773.57431.24531.39
4.Maduramicin2.30100939.65877.58473.31
5.Narasin2.58100787.59431.27531.35

Conditions

ColumnRaptor Biphenyl (cat.# 9309A12)
Dimensions:100 mm x 2.1 mm ID
Particle Size:2.7 µm
Pore Size:90 Å
Guard Column:Raptor Biphenyl EXP guard column cartridge 5 mm, 2.1 mm ID, 2.7 µm (cat.# 9309A0252)
Temp.:40 °C
Standard/Sample
Diluent:Water:methanol (10:90)
Conc.:100 ng/mL
Inj. Vol.:2 µL
Mobile Phase
A:0.5% Formic acid in water
B:0.5% Formic acid in acetonitrile
Time (min)Flow (mL/min)%A%B
0.000.53565
3.000.52575
3.010.53565
5.000.53565
DetectorMS/MS
Ion Mode:ESI+
Mode:MRM
InstrumentUHPLC
NotesWant even better performance when analyzing metal-sensitive compounds? Check out Inert LC columns at www.restek.com/inert.

Author

  • Restek Corporation

    Restek is a leading provider of chromatography columns, accessories, and certified reference materials. Trust Restek for reliable, high-quality analytical solutions.

    View all posts
FSSS2276-IT
Version: A